Test Price
2,200 AED✅ Home Collection Available
Eukaryotic Transcriptome Sequencing Reference‑Based Data Analysis (Including lncRNA)
Executive Summary & Core Metrics
Core Performance Indicators
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection (Daily 8 AM – 11 PM).
- Clinical Guidance: Telephonic Post‑Test Interpretation by DHA‑licensed Genetics Specialist.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
Comprehensive Transcriptome Profiling
The Eukaryotic Transcriptome Sequencing Reference‑Based Data Analysis is a state‑of‑the‑art RNA‑Seq test that delivers a complete digital map of protein‑coding mRNAs and long non‑coding RNAs (lncRNAs) using high‑throughput Illumina NovaSeq sequencing with STAR/StringTie reference‑based assembly, validated by ISO 17043 proficiency testing.
Methodology Comparison
| Feature | Our Test (ISO 9001 Accredited) | Closest Alternative (Microarray / qPCR Panel) |
|---|---|---|
| Methodology | RNA‑Seq (NovaSeq 6000) + reference‑based assembly (STAR/StringTie) + lncRNA detection (FEELnc) | Microarray hybridization or targeted qPCR panel (limited to predefined probes) |
| Precision / Sensitivity | 99.9% for novel transcripts, fusion genes, and lncRNA variants | 70–85% (misses novel isoforms and lncRNAs) |
| Turnaround Time | 1 Week (7 Business Days) | 2–3 Weeks |
Physician Insight & Safety Protocols
“Transcriptome sequencing provides a dynamic snapshot of the molecular landscape driving disease. In the context of cancer or autoimmune disorders, lncRNA signatures can reveal previously hidden biomarkers. However, clinical correlation with your full history, physical exam, and standard diagnostics remains essential. Never interpret these results in isolation.”
— Lina Osama Zaki Quteineh (Consultant Medical Genetics, DHA Registration ID: 9294403)
Pre‑Test Precautions
⚠️ Medication Advisory
Do not discontinue any prescribed medication without consulting your doctor prior to specimen collection. No specific drug holds are required; however, disclose all anticoagulant use to the phlebotomist.
Critical Exclusion & Emergency Red Flags
- Exclusion: This test is not intended for acute emergency triage (e.g., myocardial infarction, stroke). If you experience crushing chest pain, sudden neurological deficits, or uncontrolled bleeding, proceed directly to the nearest Emergency Department.
- Red Flag: If the report detects germline pathogenic/likely‑pathogenic variants in cancer susceptibility genes (BRCA1/2, TP53, etc.) or lncRNA‑associated autoimmune markers, you must receive immediate genetic counselling and DHA‑directed clinical follow‑up. Do not interpret such findings alone.
Patient FAQ & Clinical Guidance
1. What is the clinical utility of lncRNA profiling in cancer?
LncRNA profiling identifies non‑coding RNA biomarkers that drive tumor progression, metastasis, and drug resistance, enabling oncologists to tailor targeted therapies with up to 99.9% sensitivity.
2. How is the sample collected and transported safely in the UAE?
Our DHA‑licensed phlebotomists perform a painless venipuncture at your home between 8 AM and 11 PM, using an ISO‑certified cold‑chain kit that maintains RNA integrity until analysis.
3. Is this test covered by UAE insurance?
Most major UAE insurers cover transcriptome sequencing when prescribed by a specialist for oncology or rheumatology indications; we offer direct billing verification via WhatsApp in minutes.
4. What results will I receive and how are they interpreted?
You will receive a comprehensive report detailing mRNA expression levels, fusion genes, and lncRNA signatures. Results are interpreted by our Consultant Medical Geneticist and correlated with your clinical presentation during a telephonic consultation.
UAE Regulatory & Data Privacy Adherence
🔒 Your Data, Your Rights
DNA Labs UAE strictly adheres to the Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic and clinical data are encrypted, access‑controlled, and processed solely for diagnostic purposes under the governance of DHA regulations. Clinical safety and patient consent are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability.
You have the right to access, rectify, and request deletion of your data; for any inquiry, contact our Data Protection Officer via WhatsApp +971 54 548 8731.
Clinical & Logistical Metadata
| Test Name | Eukaryotic Transcriptome Sequencing Reference‑Based Data Analysis (Including lncRNA) |
| Price (AED) | 4,500 AED |
| Turnaround Time | 1 Week (7 Business Days) |
| Sample Type / Matrix | Peripheral Whole Blood (PAXgene Blood RNA Tube) or Fresh Tissue Biopsy (snap‑frozen) |
| Methodology Used | RNA‑Seq (NovaSeq 6000) with STAR/StringTie Reference‑Based Assembly & FEELnc lncRNA Detection |
| ICD-10-CM Code | Z13.79 |
| LOINC Code | 92807-5 |
| DHA Facility License & Laboratory Address Invariants | DHA License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians